RARECast

548 Folgen

1. Crowdsourcing Therapeutic Approaches for an Ultra-Rare Disease

   Vom: 5.2.2020
2. Delivering Oligonucleotide Therapies to Any Cell Type

   Vom: 29.1.2020
3. Protalix Looks Beyond Biobetters

   Vom: 22.1.2020
4. Driving N-of-1 Therapies for Ultra-Rare Disease Patients

   Vom: 15.1.2020
5. Cutting the Time and Cost of Drug Discovery with MicroOrgans

   Vom: 8.1.2020
6. Acquisition Combines Two Pipelines for Rare Skin Diseases

   Vom: 2.1.2020
7. Programming Cells to Produce Neuroprotective Factors to Treat ALS

   Vom: 26.12.2019
8. Origin's Rapid Path to Seek Approval for Treatment of Ultra-Rare Metabolic Condition

   Vom: 18.12.2019
9. Developing a Common Language for Rare Diseases

   Vom: 11.12.2019
10. Why Payers Lag Drug Developers and Regulators in Embracing Real-World Evidence

    Vom: 4.12.2019
11. How a Brother's Love Is Forging a Path for Customized Therapies for Rare Disease Patients

    Vom: 27.11.2019
12. Addressing the Barriers to Accessing Experimental Therapies

    Vom: 20.11.2019
13. A Journey to Advocacy

    Vom: 13.11.2019
14. Turning Chronic Illness into a Fashion Statement

    Vom: 6.11.2019
15. Connecting Young Adults with Rare and Chronic Conditions

    Vom: 30.10.2019
16. Helping Caregivers Care for Themselves

    Vom: 23.10.2019
17. A Festival of Moving Pictures

    Vom: 16.10.2019
18. Deep Genomics Boasts an AI First in Drug Discovery

    Vom: 9.10.2019
19. How to Live with a Disability with Your Mojo Intact

    Vom: 3.10.2019
20. Why a Big Pharma Exec Embraced Rare Neurological Diseases

    Vom: 25.9.2019